Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

M. E. Gore, C. Szczylik, C. Porta, S. Bracarda, G. A. Bjarnason, S. Oudard, S. H. Lee, J. Haanen, D. Castellano, E. Vrdoljak, P. Schöffski, P. Mainwaring, R. E. Hawkins, L. Crinò, T. M. Kim, G. Carteni, W. E E Eberhardt, K. Zhang, K. Fly, E. MatczakM. J. Lechuga, S. Hariharan, R. Bukowski

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Genome-wide association studies have identified multiple single-nucleotide polymorphsims (SNPs) associated with prostate cancer (PCa). Although these SNPs have been clearly associated with disease risk, their relationship with clinical outcomes is less clear. Our aim was to assess the frequency of known PCa susceptibility alleles within a single institution ascertainment and to correlate risk alleles with disease-specific outcomes.Methods:We genotyped 1354 individuals treated for localised PCa between June 1988 and December 2007. Blood samples were prospectively collected and de-identified before being genotyped and matched to phenotypic data. We investigated associations between 61 SNPs and disease-specific end points using multivariable analysis and also determined if SNPs were associated with PSA at diagnosis.Results:Seven SNPs showed associations on multivariable analysis (P

Original languageEnglish
Pages (from-to)12-19
Number of pages8
JournalBritish Journal of Cancer
Volume113
Issue number1
DOIs
Publication statusPublished - Jun 30 2015

Fingerprint

Compassionate Use Trials
Renal Cell Carcinoma
Nucleotides
Prostatic Neoplasms
Alleles
Genome-Wide Association Study
sunitinib

Keywords

  • expanded-access trial
  • prognosis
  • Renal cell carcinoma
  • sunitinib
  • tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gore, M. E., Szczylik, C., Porta, C., Bracarda, S., Bjarnason, G. A., Oudard, S., ... Bukowski, R. (2015). Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma. British Journal of Cancer, 113(1), 12-19. https://doi.org/10.1038/bjc.2015.199

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma. / Gore, M. E.; Szczylik, C.; Porta, C.; Bracarda, S.; Bjarnason, G. A.; Oudard, S.; Lee, S. H.; Haanen, J.; Castellano, D.; Vrdoljak, E.; Schöffski, P.; Mainwaring, P.; Hawkins, R. E.; Crinò, L.; Kim, T. M.; Carteni, G.; Eberhardt, W. E E; Zhang, K.; Fly, K.; Matczak, E.; Lechuga, M. J.; Hariharan, S.; Bukowski, R.

In: British Journal of Cancer, Vol. 113, No. 1, 30.06.2015, p. 12-19.

Research output: Contribution to journalArticle

Gore, ME, Szczylik, C, Porta, C, Bracarda, S, Bjarnason, GA, Oudard, S, Lee, SH, Haanen, J, Castellano, D, Vrdoljak, E, Schöffski, P, Mainwaring, P, Hawkins, RE, Crinò, L, Kim, TM, Carteni, G, Eberhardt, WEE, Zhang, K, Fly, K, Matczak, E, Lechuga, MJ, Hariharan, S & Bukowski, R 2015, 'Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma', British Journal of Cancer, vol. 113, no. 1, pp. 12-19. https://doi.org/10.1038/bjc.2015.199
Gore, M. E. ; Szczylik, C. ; Porta, C. ; Bracarda, S. ; Bjarnason, G. A. ; Oudard, S. ; Lee, S. H. ; Haanen, J. ; Castellano, D. ; Vrdoljak, E. ; Schöffski, P. ; Mainwaring, P. ; Hawkins, R. E. ; Crinò, L. ; Kim, T. M. ; Carteni, G. ; Eberhardt, W. E E ; Zhang, K. ; Fly, K. ; Matczak, E. ; Lechuga, M. J. ; Hariharan, S. ; Bukowski, R. / Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma. In: British Journal of Cancer. 2015 ; Vol. 113, No. 1. pp. 12-19.
@article{dac66c840e7a4a4ea46e067e75628786,
title = "Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma",
abstract = "Genome-wide association studies have identified multiple single-nucleotide polymorphsims (SNPs) associated with prostate cancer (PCa). Although these SNPs have been clearly associated with disease risk, their relationship with clinical outcomes is less clear. Our aim was to assess the frequency of known PCa susceptibility alleles within a single institution ascertainment and to correlate risk alleles with disease-specific outcomes.Methods:We genotyped 1354 individuals treated for localised PCa between June 1988 and December 2007. Blood samples were prospectively collected and de-identified before being genotyped and matched to phenotypic data. We investigated associations between 61 SNPs and disease-specific end points using multivariable analysis and also determined if SNPs were associated with PSA at diagnosis.Results:Seven SNPs showed associations on multivariable analysis (P",
keywords = "expanded-access trial, prognosis, Renal cell carcinoma, sunitinib, tyrosine kinase inhibitor",
author = "Gore, {M. E.} and C. Szczylik and C. Porta and S. Bracarda and Bjarnason, {G. A.} and S. Oudard and Lee, {S. H.} and J. Haanen and D. Castellano and E. Vrdoljak and P. Sch{\"o}ffski and P. Mainwaring and Hawkins, {R. E.} and L. Crin{\`o} and Kim, {T. M.} and G. Carteni and Eberhardt, {W. E E} and K. Zhang and K. Fly and E. Matczak and Lechuga, {M. J.} and S. Hariharan and R. Bukowski",
year = "2015",
month = "6",
day = "30",
doi = "10.1038/bjc.2015.199",
language = "English",
volume = "113",
pages = "12--19",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

AU - Gore, M. E.

AU - Szczylik, C.

AU - Porta, C.

AU - Bracarda, S.

AU - Bjarnason, G. A.

AU - Oudard, S.

AU - Lee, S. H.

AU - Haanen, J.

AU - Castellano, D.

AU - Vrdoljak, E.

AU - Schöffski, P.

AU - Mainwaring, P.

AU - Hawkins, R. E.

AU - Crinò, L.

AU - Kim, T. M.

AU - Carteni, G.

AU - Eberhardt, W. E E

AU - Zhang, K.

AU - Fly, K.

AU - Matczak, E.

AU - Lechuga, M. J.

AU - Hariharan, S.

AU - Bukowski, R.

PY - 2015/6/30

Y1 - 2015/6/30

N2 - Genome-wide association studies have identified multiple single-nucleotide polymorphsims (SNPs) associated with prostate cancer (PCa). Although these SNPs have been clearly associated with disease risk, their relationship with clinical outcomes is less clear. Our aim was to assess the frequency of known PCa susceptibility alleles within a single institution ascertainment and to correlate risk alleles with disease-specific outcomes.Methods:We genotyped 1354 individuals treated for localised PCa between June 1988 and December 2007. Blood samples were prospectively collected and de-identified before being genotyped and matched to phenotypic data. We investigated associations between 61 SNPs and disease-specific end points using multivariable analysis and also determined if SNPs were associated with PSA at diagnosis.Results:Seven SNPs showed associations on multivariable analysis (P

AB - Genome-wide association studies have identified multiple single-nucleotide polymorphsims (SNPs) associated with prostate cancer (PCa). Although these SNPs have been clearly associated with disease risk, their relationship with clinical outcomes is less clear. Our aim was to assess the frequency of known PCa susceptibility alleles within a single institution ascertainment and to correlate risk alleles with disease-specific outcomes.Methods:We genotyped 1354 individuals treated for localised PCa between June 1988 and December 2007. Blood samples were prospectively collected and de-identified before being genotyped and matched to phenotypic data. We investigated associations between 61 SNPs and disease-specific end points using multivariable analysis and also determined if SNPs were associated with PSA at diagnosis.Results:Seven SNPs showed associations on multivariable analysis (P

KW - expanded-access trial

KW - prognosis

KW - Renal cell carcinoma

KW - sunitinib

KW - tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84934444813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934444813&partnerID=8YFLogxK

U2 - 10.1038/bjc.2015.199

DO - 10.1038/bjc.2015.199

M3 - Article

AN - SCOPUS:84934444813

VL - 113

SP - 12

EP - 19

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -